Theodore Levin to Sensitivity and Specificity
This is a "connection" page, showing publications Theodore Levin has written about Sensitivity and Specificity.
Connection Strength
0.916
-
Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. BMC Cancer. 2018 May 02; 18(1):509.
Score: 0.149
-
Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 11 12; 29(6):672-681.
Score: 0.135
-
Colonoscopic screening of women for colorectal neoplasia. N Engl J Med. 2005 Aug 25; 353(8):844-6; author reply 844-6.
Score: 0.062
-
Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005 Jun; 54(6):807-13.
Score: 0.061
-
What does sigmoidoscopy really miss? Am J Gastroenterol. 2003 Oct; 98(10):2326-7.
Score: 0.054
-
Flexible sigmoidoscopy for colorectal cancer screening: valid approach or short-sighted? Gastroenterol Clin North Am. 2002 Dec; 31(4):1015-29, vii.
Score: 0.051
-
Colorectal cancer screening: new opportunities. Surg Oncol Clin N Am. 1999 Oct; 8(4):673-91, vi-vii.
Score: 0.041
-
A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol. 2017 Nov; 112(11):1728-1735.
Score: 0.036
-
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 04; 152(5):1217-1237.e3.
Score: 0.034
-
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 01; 112(1):37-53.
Score: 0.034
-
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 05; 164(7):456-63.
Score: 0.032
-
Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015 Mar; 81(3):575-582.e4.
Score: 0.030
-
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
Score: 0.029
-
Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7.
Score: 0.029
-
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 04; 160(3):171.
Score: 0.028
-
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
Score: 0.026
-
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008 Oct 07; 149(7):441-50, W81.
Score: 0.019
-
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007 Oct 03; 99(19):1462-70.
Score: 0.018
-
Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia. Clin Chem. 2006 Dec; 52(12):2299-302.
Score: 0.017
-
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006 May; 130(6):1865-71.
Score: 0.016
-
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006 May; 130(6):1872-85.
Score: 0.016